Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-15 · accession 0001209191-23-059263 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-19 | 2023-12-15 | ORIC | Chacko Jacob | Pres, CEO, Dir | M - OptEx | $0.00 | +38.7K | 823.1K | +5% | $0 |
| D | 2023-12-19 | 2023-12-15 | ORIC | Chacko Jacob | Pres, CEO, Dir | S - Sale+OE | $8.58 | -14.5K | 808.5K | -2% | -$124.7K |
| DM | 2023-12-19 | 2023-12-15 | ORIC | Chacko Jacob | Pres, CEO, Dir | M - OptEx | $0.00 | -38.7K | 16.7K | -70% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | M | A | 38,667 | $0.00 | 823,083 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F2) Includes 3,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2023-12-15 | S | D | 14,539 | $8.58 | 808,544 | D | — | — | (F4) Represents the weighted average share price of an aggregate total of 14,539 shares sold in the price range of $8.57 to $8.77 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Restricted Stock Unit | 2023-12-15 | M | D | 22,000 | $0.00 | 44,000 | D | — · — to — | 22,000 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F6) 1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025. |
| 4 | Derivative | Restricted Stock Unit | 2023-12-15 | M | D | 16,667 | $0.00 | 16,667 | D | — · — to — | 16,667 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F5) 1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024. |